NVST (Envista Holdings) FCF Margin % : -0.91% (As of Mar. 2025)

View and export this data going back to 2019. Start your Free Trial

What is Envista Holdings FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Envista Holdings's Free Cash Flow for the three months ended in Mar. 2025 was $-6 Mil. Envista Holdings's Revenue for the three months ended in Mar. 2025 was $617 Mil. Therefore, Envista Holdings's FCF Margin % for the quarter that ended in Mar. 2025 was -0.91%.

As of today, Envista Holdings's current FCF Yield % is 7.89%.

The historical rank and industry rank for Envista Holdings's FCF Margin % or its related term are showing as below:

NVST' s FCF Margin % Range Over the Past 10 Years
Min: 4.16 Med: 12.06 Max: 13.99
Current: 10.7

During the past 9 years, the highest FCF Margin % of Envista Holdings was 13.99%. The lowest was 4.16%. And the median was 12.06%.

NVST's FCF Margin % is ranked better than
76.65% of 818 companies
in the Medical Devices & Instruments industry
Industry Median: -2.64 vs NVST: 10.70

Envista Holdings FCF Margin % Historical Data

The historical data trend for Envista Holdings's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Envista Holdings FCF Margin % Chart

Envista Holdings Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

FCF Margin %

Get a 7-Day Free Trial

12.24

12.23

4.16

8.47

12.06

Envista Holdings Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
FCF Margin %	Get a 7-Day Free Trial															4.70	13.63	10.53	18.96	-0.91

Competitive Comparison of Envista Holdings's FCF Margin %

For the Medical Instruments & Supplies subindustry, Envista Holdings's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Envista Holdings's FCF Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Envista Holdings's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Envista Holdings's FCF Margin % falls into.

Save Embed

;

Save Embed

;

Envista Holdings FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Envista Holdings's FCF Margin for the fiscal year that ended in Dec. 2024 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2024 )	/	Revenue (A: Dec. 2024 )
	=	302.7	/	2510.6
	=	12.06 %

Envista Holdings's FCF Margin for the quarter that ended in Mar. 2025 is calculated as

FCF Margin	=	Free Cash Flow (Q: Mar. 2025 )	/	Revenue (Q: Mar. 2025 )
	=	-5.6	/	616.9
	=	-0.91 %

Envista Holdings FCF Margin % Related Terms

Thank you for viewing the detailed overview of Envista Holdings's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Envista Holdings Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Envista Holdings Corp (NYSE:NVST) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

NVST:Mexico 0HV:Germany

Address

200 S. Kraemer Boulevard, Building E, Brea, CA, USA, 92821-6208

Website

https://www.envistaco.com

Envista Holdings Corp is a dental products company. It develops, manufactures, and markets portfolios of dental consumables, equipment, and services to dental professionals. The company's business consists of two segments; Specialty Products & Technologies and Equipment & Consumables. The company's Specialty Products & Technologies segment, which derives key revenue, develops, manufactures, and markets dental implant systems, including regenerative solutions, dental prosthetics, and associated treatment software and technologies, as well as orthodontic bracket systems, aligners, and lab products. Geographically, the company generates a majority of its revenue from North America, followed by Western Europe and other developed and emerging markets.

Executives

Eric Conley	officer: SVP, Orthodontics	200 S. KRAEMER BLVD, BLDG E, BREA CA 92821
Mark E Nance	officer: Senior Vice President, GC, Sec	1333 S SPECTRUM BLVD #100, CHANDLER AZ 85286
Stephen Keller	officer: Principal Financial Officer	200 S. KRAEMER BLVD., BUILDING E, BREA CA 92821
Amir Aghdaei	director, officer: PRESIDENT AND CEO	C/O CREDENCE SYSTEMS CORPORATION, 1421 CALIFORNIA CIRCLE, MILPITAS CA 95035
Faez C Kaabi	officer: Chief Accounting Officer	200 S. KRAEMER BLVD., BUILDING E, BREA CA 92821
Howard H Yu	officer: SENIOR VICE PRESIDENT, CFO	250 S. KRAEMER BLVD., BREA CA 92821
Mischa Reis	officer: SENIOR VICE PRESIDENT	C/O ENVISTA HOLDINGS CORPORATION, 200 S. KRAEMER BLVD, BLDG. E, BREA CA 92821
Curt W Bludworth	officer: SENIOR VICE PRESIDENT, CHRO	250 S. KRAEMER BLVD., BREA CA 92821
Barbara B. Hulit	director	C/O FORTIVE CORPORATION, 6920 SEAWAY BLVD, EVERETT WA 98203
Jeffrey Kappler	officer: SENIOR VICE PRESIDENT	C/O ENVISTA HOLDINGS CORPORATION, 200 S. KRAEMER BLVD, BLDG. E, BREA CA 92821
Teresa Gayle Sheppard	director	C/O ENVISTA HOLDINGS CORPORATION, 200 S. KRAEMER BLVD., BLDG. E, BREA CA 92821
Vivek Jain	director	ICU MEDICAL, INC., 951 CALLE AMANECER, SAN CLEMENTE CA 92673
Jean-claude Kyrillos	officer: Senior Vice President	C/O ENVISTA HOLDINGS CORPORATION, 200 S. KRAEMER BLVD., BLDG. E, BREA CA 92821
Kieran Gallahue	director	PO BOX 684369, PARK CITY UT 84068
William K Daniel	director	2135 WEST MAPLE ROAD, TROY MI 48084